• 목록

국내외 제약바이오기업의 ESG 대응 현황 및 시사점

KDB미래전략연구소 산업기술리서치센터

김성재 전임연구원(landofice@kdb.co.kr)

Ⅰ. 들어가며

Ⅱ. 제약바이오산업 ESG 제도ž평가 현황

Ⅲ. 해외 제약바이오기업 ESG 대응 현황

Ⅳ. 국내 제약바이오기업 ESG 대응 현황 및 시사점

출처 : https://rd.kdb.co.kr/BOUBUF02N00.act?GmBrnId=&tabYn=&popupYn=&replyCntYn=&ECY_PWD=&_mnuId=FYERER0017&_PARAM_NAME=NEXT_DATA&_PARM_DATA=%7B%22ITR_NAC_ID_MNG_SNO%22%3A%22169977%22%2C%22ITR_BLB_ID%22%3A%22STD423%22%2C%22NAC_SNO%22%3A%22%22%2C%22SEARCH_CONDITION%22%3A%22ZZ%22%2C%22SEARCH_KEYWORD%22%3A%22%22%2C%22SEARCH_CATEGORY%22%3A%22%22%2C%22ORDER_TYPE%22%3A%22new%22%2C%22FIRST_MENU_ID%22%3A%22FLSRIA02N01%22%2C%22TAB%22%3A%22%22%2C%22viewPage%22%3A%2210%22%2C%22searchCondition%22%3A%22ZZ%22%2C%22searchKeyword%22%3A%22%22%2C%22searchCategory%22%3A%22%22%2C%22inqCntSotYn%22%3A%22sortNew%22%2C%22pageNo%22%3A1%2C%22GmBrnId%22%3A%22%22%2C%22tabYn%22%3A%22%22%2C%22popupYn%22%3A%22%22%2C%22replyCntYn%22%3A%22%22%7D&_PARM_DATA_SIGN=1840392495#__init__